SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹87,693 Cr | ₹81,396 Cr | ₹77,225 Cr | ₹66,958 Cr | ₹64,110 Cr |
What is the latest Total Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹87,693 Cr |
| Mar2024 | ₹81,396 Cr |
| Mar2023 | ₹77,225 Cr |
| Mar2022 | ₹66,958 Cr |
| Mar2021 | ₹64,110 Cr |
How is Total Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹87,693 Cr | 7.74 | |
| Mar2024 | ₹81,396 Cr | 5.40 | |
| Mar2023 | ₹77,225 Cr | 15.33 | |
| Mar2022 | ₹66,958 Cr | 4.44 | |
| Mar2021 | ₹64,110 Cr | - | |
Compare Total Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,609.4 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
| MANKIND PHARMA | ₹85,019.3 Cr | -0.4% | -10.9% | -16.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 4% |
-4.9% |
-2.3% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses